1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Motherisk Update 2014
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting,
Details to be announced
- Read more in our News Archive
Current Studies at Motherisk
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Cancer in Pregnancy
The occurrence of cancer during pregnancy is a rare and challenging event. But as more and more women delay child-bearing until later in life, the rate of cancer in pregnancy is expected to rise. New clinical practice guidelines have been prepared by the Chemotherapy During Pregnancy Working Group and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.
The lead author of the Guidelines is Dr. Gideon Koren, Director of the Motherisk Program. The guidelines were published in March 2013 and are available online in Acrobat format at http://sogc.org/guidelines/documents/gui288CPG1303E.pdf.
Information is also available in Cancer in Pregnancy and Lactation: The Motherisk Guide. Published in 2011, this book contains evidence-based information needed to address the complex issues of maternal diagnosis, management, treatment, prognosis and long-term impact on the unborn child. Co-edited by recognized experts in the field with over 25 years' experience, this comprehensive volume is essential reading for all maternal-fetal medicine physicians, obstetricians, neonatologists, oncologists, and pharmacologists.
The information on the Motherisk/Hospital for Sick Children World Wide Web Site has been developed specifically for The Hospital for Sick Children. It is provided for informational purposes for qualified health care professionals. This material is not intended as a substitute for consulting qualified health care professionals. Patient circumstances will vary and some information may have become outdated as a result of more recent medical developments. The Hospital for Sick Children and Motherisk accept no responsibility for reliance on the information set out in this Web Site.
Reasonable effort has been made to ensure the accuracy of drug doses; however, readers must confirm and follow the doses and schedules set out by manufacturers. The Hospital for Sick Children and Motherisk accept no responsibility for reliance on the drug doses set out herein.